Innovation Pharmaceuticals Inc.
IPIX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$102.8K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $102,803.00 |
|---|---|
| Enterprise Value | $77,803.00 |
| Earnings per Share | $-0.01 |
| Beta | -0.49 |
| Outstanding Shares | 518,347,691 |
Return
| Return on Equity | -228.14% |
|---|---|
| Return on Assets | -39.76% |
| Return on Invested Capital | -158.37% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.08 |
| Price to Sales | -0.0 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -12.97 |
| Enterprise Value to EBIT | -0.03 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 10.78 |
| Debt to Equity | 0.72 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Innovation Pharmaceuticals Inc.
4 employees
CEO: Leo Ehrlich
Innovation Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to the development of small molecule therapies. Its pipeline targets a range of medical areas, including inflammatory diseases, cancer, dermatology, ...